In the pharmaceutical industry, products that benefit from the stabilising effects of trehalose include, but are not limited to, monoclonal antibodies (mAb), antibody drug conjugates (ADC), fusion proteins, peptides, stem cells and vaccines.
In the pharmaceutical industry, products that benefit from the stabilising effects of trehalose include, but are not limited to, monoclonal antibodies (mAb), antibody drug conjugates (ADC), fusion proteins, peptides, stem cells and vaccines.